Medtronic plc (MDT)
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Medtronic (MDT) closed at $88.65, marking a +2.58% move from the previous day.
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Medtronic (MDT) concluded the recent trading session at $85.74, signifying a -1.61% move from its prior day's close.
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?
Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain treatments.
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Glenmede Investment Management LP Decreases Stake in Medtronic PLC $MDT
Glenmede Investment Management LP cut its stake in shares of Medtronic PLC (NYSE: MDT) by 5.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 507,406 shares of the medical technology company's stock after selling 31,401 shares during the quarter.
Game Creek Capital LP Has $5.83 Million Stock Position in Medtronic PLC $MDT
Game Creek Capital LP increased its position in shares of Medtronic PLC (NYSE: MDT) by 231.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 61,250 shares of the medical technology company's stock after buying an additional 42,750 shares during
Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Medtronic plc (MDT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
MiniMed Group: Medtronic's Diabetes Business Does Not Convince
MiniMed Group trades at a modest 2x sales but struggles with persistent operating losses despite 10-15% annual revenue growth. The IPO priced below range at $20/share, raising $560M; Medtronic retains 90% ownership, and MiniMed holds $350M net cash. MiniMed faces intense competition and execution risks as a standalone entity, with profitability elusive despite a large addressable diabetes market.
Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut
Shares of MiniMed , the diabetes business of medical device maker Medtronic , opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion.
Medtronic's diabetes unit MiniMed raises $560 million in US IPO
MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering.
Medtronic Debuts MiniMed Go Smart MDI With Simplera Sensor in Europe
MDT launches MiniMed Go Smart MDI with the Simplera sensor in Europe, advancing connected insulin care as the Diabetes unit's IPO plans progress.
